9th Annual Biomarkers Congress
Collaborative Ependymoma Research Network (CERN)
Lake Las Vegas
4617 Birch Street,
Bellaire TX 77401-5509 , TX
http://

Schedule of Presentations:

Saturday, November 22, 2008
08:00:00 Keynote Speaker Richard J Gilbertson
08:30:00 Stem Cell-Related Self Renewal Signature Associated With Resistance To Chemoradiotherapy In Glioblastoma. Monika Hegi
08:45:00 A Novel Small Molecule Inhibitor Of The Jak2/STAT3 Pathway Blocks Self-Renewal And Induces Apoptosis In Brain Tumor Stem Cells.
09:00:00 CD133+ Expression In The Brain And High-Grade Glioma Of A Mouse Model With A lacZ Reporter Knock-In At The CD133 Locus. Adilia Hormigo
09:15:00 Clonal Analysis Reveals A Hierarchy Of Self-Renewing Tumor-Initiating Cell Types In Glioblastoma Heidi Phillips
09:30:00 Isolation Of Mesenchymal Stem Cells From The Normal Brain: Implications For The Glioma Microenvironment. S Kang
09:45:00 Isolation Of Brain Cancer Stem Cells From Glioblastoma Using An Antibody Library. Tal Raveh
10:00:00 BREAK
10:15:00 Keynote speaker David Largaespada
10:45:00 Oncolytic Virus SVV-001 Selectively Kills Cancer Stem Cells And Eradicates Medulloblastomas In Primary Tumor-Based Intra-Cerebellar Xenograft Mouse Models Xiao Nan Li
11:00:00 The Functional Role Of Y Box Binding Protein 1(YB-1) In Pediatric Glioblastoma Multiforme (pGBM).
12:00:00 LUNCH
13:00:00 Loss Of GATA4 And GATA6 Are Negative Prognostic Markers Of GBMs And Are Frequently Lost In Several Glioma Subtypes. Sameer Agnihotri
13:10:00 MGMT Promoter Methylation As An Independent Prognostic Factor In The Absence Of Alkylating Chemotherapy In Glioblastoma. Andreana Rivera
13:20:00 Multiplex Ligation-Dependent Probe Amplification (MLPA) Analysis: A Robust Tool For Detection Of Epidermal Growth Factor Receptor (EGFR) Variant III And EGFR Amplification In Gliomas In A Routine Diagnostic Setting. Pieter Wesseling
13:30:00 YKL-40 And Matrix Metalloproteinase-9 (MMP-9) As Serum Tumor Markers In Gliomas. Fabio Iwamoto
13:40:00 Prognostic Relevance Of MGMT Promoter Methylation As Demonstrated In Serial Stereotactic Specimens From Anaplastic Astrocytomas And Glioblastomas After Primary Radio-/ Radiochemotherapy. Niklas Thon
13:50:00 FoxM1 Overexpression And DNA Amplification In Pediatric Astrocytomas Graeme Hodgson
14:00:00 Parallel Copy Number Variation And Gene Expression Profiling Of Human Glioblastoma: A Study Based On TCGA Data Analysis. Yong Wan Kim
14:10:00 Concerns About Angiogenesis Inhibition As Treatment For High Grade Astrocytomas. Joost Verhoeff
14:20:00 Integrated Genomic And Proteomic Analysis Identifies Distinct GBM Subclasses. Cameron W Brennan
14:30:00 Nogo-A As A Possible Marker For Oligodendroglial Tumors, Especially Oligodendrogliomas. Tae Young Jung
14:40:00 MGMT Assessed With Methylation-Specific (MS-) Multiplex Ligation-Dependent Probe Amplification (MLPA) Predicts Outcome To Temozolomide In Progressive Low-Grade Astrocytoma After Radiotherapy. Walter Taal
14:50:00 Clinical, Histological And Immunohistochemical Factors Governing Recurrence In Medulloblastomas. Anandh Balasubramaniam
15:00:00 The Incidence Of Expression, Prognostic Impact And Correlation With The Degree Of Inflammatory Response Of p-STAT3 In Human Malignant Gliomas. Mohamed Abou Ghazal
15:00:00 BREAK
15:15:00 SELECT POSTER VIEWING II
16:15:00 SELECT POSTER DISCUSSION II
17:00:00 GENERAL POSTER SESSION
19:00:00 SNO BANQUET
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.